Cardiology

Researchers uncover common heart drug's link to diabetes

McMaster University researchers may have found a novel way to suppress the devastating side effect of statins, one of the worlds' most widely used drugs to lower cholesterol and prevent heart disease.

Cardiology

Evolocumab superior to ezetimibe in lowering LDL cholesterol

Evolocumab, an injected form of a class of drugs called PCSK9 inhibitors that lower low-density lipoprotein cholesterol, also known as LDL-C or "bad cholesterol," outperformed ezetimibe with few side effects in patients unable ...

page 7 from 14